H7791
Interleukin-17A human
IL-17A, recombinant, expressed in HEK 293 cells, HumanKine®, suitable for cell culture
Manufacturer: Sigma Aldrich
Synonym(S): CTLA-8, IL-17
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 10 μG | H7791-10-μG | In Stock | ₹ 21,756.00 |
H7791 - 10 μG
In Stock
Quantity
1
Base Price: ₹ 21,756.00
GST (18%): ₹ 3,916.08
Total Price: ₹ 25,672.08
biological source
human
Quality Level
100
recombinant
expressed in HEK 293 cells
Assay
≥95% (SDS-PAGE)
form
lyophilized powder
potency
≤2 ng/mL EC50
quality
endotoxin tested
mol wt
dimer 30-35 kDa (glycosylated)
packaging
pkg of 10 μg
technique(s)
cell culture | mammalian: suitable
Related Products
Description
- Biochem/physiol Actions: IL-17, initially known as CTLA-8, is a T cell-expressed polypeptide that appears to be involved in the regulation of the hematopoietic system. IL-17 has been shown to induce IL-6, IL-8, and G-CSF production by fibroblasts; all of these cytokines have demonstrated effects on hematopoiesis.
- Physical form: Lyophilized from a 0.2 μm filtered solution of 10 mM Tris-HCl pH 7.4+ 250 mM NaCl
- Preparation Note: HumanKine Interleukin-17A (IL-17A), expressed in human HEK 293 cells, is a glycosylated homodimer with an apparent molecular mass of 30-35 kDa due to glycosylation. Production in human 293 cells offers authentic glycosylation. Glycosylation contributes to stability in cell growth media and other applications.
- Analysis Note: The specific activity was determined by the dose-dependent induction of IL-6 secretion from NDHF adult fibroblasts.
- Legal Information: HumanKine is a registered trademark of Proteintech Group, Inc. and Humanzyme, Inc
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
biological source: human
Quality Level: 100
recombinant: expressed in HEK 293 cells
Assay: ≥95% (SDS-PAGE)
form: lyophilized powder
potency: ≤2 ng/mL EC50
quality: endotoxin tested
mol wt: dimer 30-35 kDa (glycosylated)
packaging: pkg of 10 μg
technique(s): cell culture | mammalian: suitable
biological source:
human
Quality Level:
100
recombinant:
expressed in HEK 293 cells
Assay:
≥95% (SDS-PAGE)
form:
lyophilized powder
potency:
≤2 ng/mL EC50
quality:
endotoxin tested
mol wt:
dimer 30-35 kDa (glycosylated)
packaging:
pkg of 10 μg
technique(s):
cell culture | mammalian: suitable
biological source: human
Quality Level: 100
recombinant: expressed in HEK 293 cells
Assay: ≥95% (SDS-PAGE)
form: lyophilized powder
potency: ≤10 ng/mL EC50
quality: __
mol wt: dimer 38 kDa (glycosylated)
packaging: pkg of 10 μg
technique(s): cell culture | mammalian: suitable
biological source:
human
Quality Level:
100
recombinant:
expressed in HEK 293 cells
Assay:
≥95% (SDS-PAGE)
form:
lyophilized powder
potency:
≤10 ng/mL EC50
quality:
__
mol wt:
dimer 38 kDa (glycosylated)
packaging:
pkg of 10 μg
technique(s):
cell culture | mammalian: suitable
biological source: __
Quality Level: 200
recombinant: __
Assay: ≥99% (TLC)
form: powder
potency: __
quality: __
mol wt: __
packaging: __
technique(s): __
biological source:
__
Quality Level:
200
recombinant:
__
Assay:
≥99% (TLC)
form:
powder
potency:
__
quality:
__
mol wt:
__
packaging:
__
technique(s):
__
biological source: __
Quality Level: 200
recombinant: __
Assay: ≥99% (TLC)
form: powder
potency: __
quality: __
mol wt: __
packaging: __
technique(s): __
biological source:
__
Quality Level:
200
recombinant:
__
Assay:
≥99% (TLC)
form:
powder
potency:
__
quality:
__
mol wt:
__
packaging:
__
technique(s):
__